#vaccine cancers

[lemondeabicyclette]

La pathologiste suédoise Ute Krüger, spécialisée depuis 25 ans dans le diagnostic du cancer du sein, a observé une augmentation alarmante des cas de cancers du sein à croissance rapide et de maladies auto-immunes depuis le début de la campagne de vaccinations Covid en 2021, en particulier chez les jeunes femmes, qui étaient moins touchées auparavant. Ute Krüger MD, DMedSci est une pathologiste formée en Allemagne qui vit et travaille maintenant en Suède. Elle a rédigé sa thèse de doctorat à l'Université Humboldt de Berlin sur l'analyse de 7500 protocoles d'autopsie. Avec plus de 25 ans d'expérience en pathologie clinique et un intérêt particulier pour le cancer du sein, Ute fait des recherches sur le cancer du sein à l'Université de Lund depuis près de 8 ans. Elle a été membre du conseil d'administration de l'Association suédoise des pathologistes et était auparavant médecin chef du département de pathologie clinique à Växjö. Elle travaille comme médecin-chef au département de pathologie clinique de Kalmar.

[marzipanandminutiae]

As someone who works with social history for a living, I feel like I’m the aggressive opposite of an anti-vaxxer

I fucking LOVE vaccines, friends. Give me the science stab. I’m so ready. it’s a beautiful day to not die of a Bajillion and one diseases that carried off like half the population before they had even reached age 10, and a significant portion before they made it to old age, 150 years ago

I go to the old cemetery. I see the vast numbers of infant and child and young adult graves. And then I go to my doctor and get injected with Potion of Fuck That Noise. This is beautiful and miraculous and I do not remotely understand how some people can reject it – not just for themselves, but for their children

[odinsblog]

🗣️This is important!

America’s puritanical, homophobic, anti-vaccination, anti-sex education, “morality” mentality is killing people.

This information could literally save someone’s life. Please share.

Links:

👉🏿 https://www.businessinsider.com/oral-sex-is-the-leading-risk-factor-throat-cancer-expert-2023-4

👉🏿 https://www.nbcnews.com/health/cancer/hpv-can-cause-cancer-many-people-dont-realize-rcna79597

👉🏿 https://www.gardasil9.com/adults/hpv-faq/

👉🏿 https://www.mayoclinic.org/diseases-conditions/hpv-infection/in-depth/hpv-vaccine/art-20047292

[reasonsforhope]

Article

"Every year, over 350,000 women die from cervical cancer and another 660,000 are diagnosed. [Note: Plus trans men and other trans people with a cervix.] As a consequence, children are orphaned, families impoverished and communities diminished by the loss of mothers, wives, daughters and sisters. 

And yet, unlike most other cancers, almost all these cases and deaths can be averted. We have powerful vaccines that can prevent infection with the human papillomavirus (HPV) that causes cervical cancer; we have diagnostics to detect it early; and we have treatments for those it strikes. With these tools, cervical cancer can not only be stopped; it could become the first cancer to be eliminated. Some high-income countries are already close to elimination, meaning fewer than four cases per 100,000 women.

But in many low- and middle-income countries, these tools are still not available, which is why 94% of cervical cancer deaths occur in those countries. 

In 2018, WHO launched a global call to action to eliminate cervical cancer, which was followed in 2020 by the adoption by all 194 WHO Member States of a Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. The strategy calls for countries to achieve three targets by 2030: 90% of girls fully immunised against HPV; 70% of women receiving timely screening; and 90% of those found with precancer or cancer accessing treatment.

These targets are not just aspirational, they are achievable, even in low- and middle-income countries.  Bhutan has already reached the targets, the first to do so in the South-East Asia region. 

Since introducing the HPV vaccine in 2011, Rwanda has reached vaccine coverage of 90%, and today announced its national goal to reach the 90-70-90 targets three years ahead of schedule, by 2027. Already, in two districts – Gicumbi and Karongi – Rwanda is meeting those goals. Nigeria, which introduced the HPV vaccine in October last year [2023], has already vaccinated 12.3 million girls.  

We have the tools and the opportunity to eliminate cervical cancer. 

Since WHO issued the global call to action in 2018, more than 60 countries have introduced the HPV vaccine into their immunisation programmes, bringing the total to 144 countries that are routinely protecting girls from cervical cancer in later life. With scientific advances, we can now prevent cervical cancer with just a single dose, which 60 countries are now doing.  

The largest provider of HPV vaccines to low- and middle-income countries is Gavi, the Vaccine Alliance, which plans to vaccinate 120 million children between now and 2030. But this plan requires that investments in health are sustained. We are also counting on manufacturers to confirm and honour their commitments to provide HPV vaccines to low- and middle-income countries in the coming years, to avoid the supply constraints that held back progress in the past.

But we cannot rely on vaccines alone. The impact of the rapid scale-up in vaccinating girls now will not be seen for decades, when they reach the adult years when cervical cancer typically appears. To save lives now, we must match the increase  in vaccination with increases in screening and treatment. 

Decades ago, as more women gained access to pap smears in developed countries, the mortality associated with cervical cancer dropped rapidly. Today, even better tests are available. Over 60 countries now include high-performance HPV tests as part of their screening programs. Women can even collect their own samples for HPV testing, removing more barriers to life-saving services. In Australia – which is on track to become one of the first countries in the world to achieve elimination – more than a quarter of all screening tests are now done this way...

Several countries are also investigating the use of artificial intelligence to enhance the accuracy of screening in resource-limited settings. When women are found with precancerous lesions, many are now treated with portable battery-powered devices, which can be operated in remote locations."

-via The Telegraph, November 18, 2024. Article written by Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO).

[undead-knick-knack]

Wishing a Sam a speedy recovery and smiley day! 💛🥹

[mindblowingscience]

The mRNA revolution continues. Just a few years after mRNA vaccines proved their efficacy against COVID-19, scientists are now turning their attention to lung cancer. The mRNA vaccine, known as BTN116, developed by the German biotechnology company BioNTech, is the first of its kind and has entered phase 1 clinical trials in seven countries, including the United States and the United Kingdom. This vaccine is designed to treat non-small cell lung cancer (NSCLC), the most common form of the disease.

Continue Reading.

[kangals]

some of my fave pieces of Great Dog Advice I’ve seen people give include:

-You do not need to impose exercise restrictions on an injured or post-surgical dog, because dogs will never over-exert themselves.

-only deworm your dog on a full moon.

-dogs will only eat food that is good for them; they naturally know to avoid toxins

-dogs should be allowed to breed freely because they will only mate with the most fit partners.

-some dogs simply should never have their hair groomed or cut because it will make them feel bad about how they look.

[grrlscientist]

this will drive the antivaxxers absolutely bonkers, cuz SCIENCE BITCHES, IT WORKS

[oifaaa]

I have a fun new game I'm playing where anytime I find out something good a vaccine has done I share that news with my deeply anti vax mother I know it won't change her mind but it makes me happy anyway today I learned that the HPV vaccination programme the UK started in 2008 has managed to cut down the amount of cervical cancer cases by 90% in England

[typicalbrunette]

The cancer diagnosis and treatment that Sam got would have been incredibly difficult and devastating to just about anyone but to find out you have tonsil cancer as a professional voice actor and singer??? The heartbreak Sam and his family must have gone through. It must have been absolute hell.

I’m so glad he’s in recovery and I hope he continues to get better and stay healthy. I’m so glad that he’s maintained his ability to speak. I hope he’s able to sing again as well, if only because we all know how important music and singing is to him. I’m glad he was able to maintain his privacy during the really hard times, and I’m really, really glad he has such loving family and friends to support him.

Get your HPV vaccines and get your kids their HPV vaccines. It saves lives.

[dosesofcommonsense]

A cured patient is money lost

[jangillman]

[bakafox]

So Sam has come out with why he's been gone, and is encouraging everyone who's in the right age groups to get the HPV Virus vaccine because cancer sucks, and he's just had first hand experience as to it sucking.

[arabella-strange]

Sam Riegel ❤️🎗️, you kind, lovely, generous man

also, GET VACCINATED

[reasonsforhope]

"Doctors have begun trialling the world’s first mRNA lung cancer vaccine in patients, as experts hailed its “groundbreaking” potential to save thousands of lives.

Lung cancer is the world’s leading cause of cancer death, accounting for about 1.8m deaths every year. Survival rates in those with advanced forms of the disease, where tumours have spread, are particularly poor.

Now experts are testing a new jab that instructs the body to hunt down and kill cancer cells – then prevents them ever coming back. Known as BNT116 and made by BioNTech, the vaccine is designed to treat non-small cell lung cancer (NSCLC), the most common form of the disease.

The phase 1 clinical trial, the first human study of BNT116, has launched across 34 research sites in seven countries: the UK, US, Germany, Hungary, Poland, Spain and Turkey.

The UK has six sites, located in England and Wales, with the first UK patient to receive the vaccine having their initial dose on Tuesday [August 20, 2024].

Overall, about 130 patients – from early-stage before surgery or radiotherapy, to late-stage disease or recurrent cancer – will be enrolled to have the jab alongside immunotherapy. About 20 will be from the UK.

The jab uses messenger RNA (mRNA), similar to Covid-19 vaccines, and works by presenting the immune system with tumour markers from NSCLC to prime the body to fight cancer cells expressing these markers.

The aim is to strengthen a person’s immune response to cancer while leaving healthy cells untouched, unlike chemotherapy.

“We are now entering this very exciting new era of mRNA-based immunotherapy clinical trials to investigate the treatment of lung cancer,” said Prof Siow Ming Lee, a consultant medical oncologist at University College London hospitals NHS foundation trust (UCLH), which is leading the trial in the UK.

“It’s simple to deliver, and you can select specific antigens in the cancer cell, and then you target them. This technology is the next big phase of cancer treatment.”

Janusz Racz, 67, from London, was the first person to have the vaccine in the UK. He was diagnosed in May and soon after started chemotherapy and radiotherapy.

The scientist, who specialises in AI, said his profession inspired him to take part in the trial. “I am a scientist too, and I understand that the progress of science – especially in medicine – lies in people agreeing to be involved in such investigations,” he said...

“And also, I can be a part of the team that can provide proof of concept for this new methodology, and the faster it would be implemented across the world, more people will be saved.”

Racz received six consecutive injections five minutes apart over 30 minutes at the National Institute for Health Research UCLH Clinical Research Facility on Tuesday.

Each jab contained different RNA strands. He will get the vaccine every week for six consecutive weeks, and then every three weeks for 54 weeks.

Lee said: “We hope adding this additional treatment will stop the cancer coming back because a lot of time for lung cancer patients, even after surgery and radiation, it does come back.” ...

“We hope to go on to phase 2, phase 3, and then hope it becomes standard of care worldwide and saves lots of lung cancer patients.”

The Guardian revealed in May that thousands of patients in England were to be fast-tracked into groundbreaking trials of cancer vaccines in a revolutionary world-first NHS “matchmaking” scheme to save lives.

Under the scheme, patients who meet the eligibility criteria will gain access to clinical trials for the vaccines that experts say represent a new dawn in cancer treatment."

-via The Guardian, May 30, 2024

[mindblowingscience]

A personalized vaccine for glioblastoma – the most aggressive and fatal type of brain cancer – has extended the survival of four humans in the first clinical trial of its kind. The newly fashioned medicine works by supplying the immune system with a way to 'recognize' the tumor and an 'instruction manual' for its entire transcriptome. This reveals where each and every gene in the tumor can be turned on or off. Equipped with such vital information, the immune system can reprogram the cancer's defenses and launch a more successful attack.

Continue Reading.